DFIN Completes Acquisition of eBrevia
Get Alerts DFIN Hot Sheet
Join SI Premium – FREE
CHICAGO--(BUSINESS WIRE)-- Donnelley Financial Solutions (NYSE: DFIN) today announced that it has completed the previously announced acquisition of eBrevia.
About Donnelley Financial Solutions (DFIN)
DFIN is a leading global risk and compliance solutions company. We provide domain expertise, enterprise software and data analytics for every stage of our clients’ business and investment lifecycles. Markets fluctuate, regulations evolve, technology advances, and through it all, DFIN delivers confidence with the right solutions in moments that matter. Learn about DFIN’s end-to-end risk and compliance solutions online at DFINsolutions.com or you can also follow us on Twitter @DFINSolutions or on LinkedIn.
Use of Forward-Looking Statements
This news release may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements and any such forward-looking statements are qualified in their entirety by reference to the following cautionary statements. All forward-looking statements speak only as of the date of this news release and are based on current expectations and involve a number of assumptions, risks and uncertainties that could cause the actual results to differ materially from such forward-looking statements. Readers are strongly encouraged to read the full cautionary statements contained in Donnelley Financial Solutionsâ filings with the SEC. Donnelley Financial Solutions disclaims any obligation to update or revise any forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181227005027/en/
Investor Contact:
Justin Ritchie
[email protected]
Source: Donnelley Financial Solutions
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Merck's KEYTRUDA and WELIREG combination for kidney cancer
- Arcadia Biosciences closes $4 million private placement
- Shake Shack names Christiane Pendarvis to board of directors
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Twitter, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share